KEGG   DRUG: Trastuzumab pamirtecan
Entry
D12978                      Drug                                   
Name
Trastuzumab pamirtecan (USAN)
Class
Antineoplastic
 DG01918  Tyrosine kinase inhibitor
  DG01917  Receptor tyrosine kinase inhibitor
   DG03158  HER2 inhibitor
Efficacy
Antineoplastic
  Type
Antibody-drug conjugate
Target
ERBB2 (HER2, CD340) [HSA:2064] [KO:K05083]
TOP1 [HSA:7150] [KO:K03163]
Interaction
Brite
Drug groups [BR:br08330]
 Antineoplastic
  DG01918  Tyrosine kinase inhibitor
   DG01917  Receptor tyrosine kinase inhibitor
    DG03158  HER2 inhibitor
     D12978  Trastuzumab pamirtecan
Target-based classification of drugs [BR:br08310]
 Protein kinases
  Receptor tyrosine kinases (RTK)
   EGFR family
    ERBB2 (HER2, CD340)
     D12978  Trastuzumab pamirtecan (USAN)
 Enzymes
  Isomerases (EC5)
   DNA topoisomerase
    TOP1
     D12978  Trastuzumab pamirtecan (USAN)
Other DBs
CAS: 2792722-57-5
PubChem: 504099494
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system